Patent · US Active

Pharmaceutical composition comprising amniotic fluid stem cell spheroid and the use thereof in treatment of urinary incontinence

US11766460B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

U-Neuron Biomedical Inc. · TW

Inventors

Shiaw-Min Hwang · Hsinchu, TW
Shing-Hwa Lu · Taipei, TW
Kuei-Chang Li · Taipei, TW
Wei Wang · Beijing, CN

Key dates

Filing date	Dec 10, 2020
Grant date	Sep 26, 2023
Priority date	—
Expiry date	Jan 9, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P13/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein is a use of an amniotic fluid stem cell spheroid in the preparation of a composition or pharmaceutical composition for treating urinary incontinence, wherein said pharmaceutical composition may further comprise hyaluronic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.